Literature DB >> 7398539

Antibiotic-associated pseudomembranous colitis: pathogenesis and management.

M R Keighley.   

Abstract

Antibiotic-associated colitis is a potentially lethal condition which may occur quite commonly in postsurgical patients who have received prophylactic or therapeutic antimicrobial drugs. The disorder can be easily detected by assay of the specific faecal toxin. Prompt therapy by oral vancomycin is mandatory, to reduce not only mortality but also the danger of cross infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398539     DOI: 10.2165/00003495-198020010-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  23 in total

1.  Postoperative pseudomembranous enterocolitis.

Authors:  J D PETTET; A H BAGGENSTOSS; W H DEARING; E S JUDD
Journal:  Surg Gynecol Obstet       Date:  1954-05

2.  Pseudomembranous colitis and co-trimoxazole.

Authors:  A Cameron; M Thomas
Journal:  Br Med J       Date:  1977-05-21

3.  Pseudomembranous colitis associated with cephazolin therapy.

Authors:  H J Fee; M E Ament; E C Holmes
Journal:  Am J Surg       Date:  1977-02       Impact factor: 2.565

4.  Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery.

Authors:  M R Keighley; Y Arabi; J Alexander-Williams; D Youngs; D W Burdon
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

5.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

6.  Oral vancomycin for antibiotic-associated pseudomembranous colitis.

Authors:  F Tedesco; R Markham; M Gurwith; D Christie; J G Bartlett
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

7.  Letter: Pseudomembranous colitis after amoxycillin.

Authors:  S Simila; K Kouvalainen; P Makela
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

8.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

9.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

10.  Diagnosis of pseudomembranous colitis.

Authors:  A Kappas; N Shinagawa; Y Arabi; H Thompson; D Burdon; F Dimock; R H George; J Alexander-Williams; M R Keighley
Journal:  Br Med J       Date:  1978-03-18
View more
  9 in total

1.  The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.

Authors:  R E Ariano; G G Zhanel; G K Harding
Journal:  CMAJ       Date:  1990-05-15       Impact factor: 8.262

2.  Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients.

Authors:  L V McFarland; G W Elmer; W E Stamm; M E Mulligan
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Treatment of Recurrent Clostridium difficile Diarrhea.

Authors:  Elizabeth S Huebner; Christina M Surawicz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-03

4.  Clostridium difficile toxin-induced intestinal secretion in rabbit ileum in vitro.

Authors:  S Hughes; G Warhurst; L A Turnberg; N B Higgs; L G Giugliano; B S Drasar
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

5.  Antibiotic-associated colitis--the continuing saga.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

6.  Trends in Clostridium difficile Disease: Epidemiology and Intervention.

Authors:  David J Riddle; Erik R Dubberke
Journal:  Infect Med       Date:  2009

Review 7.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

8.  Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii.

Authors:  R D Toothaker; G W Elmer
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

9.  Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis.

Authors:  R J Dickinson; H J O'Connor; I Pinder; I Hamilton; D Johnston; A T Axon
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.